Atlas Trials

Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer

Clinical trial NCT07311317 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07311317
Sponsor
West China Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Start date
2026-01-01
Primary completion
2027-01-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.